Nateglinide

ATC A10BX03 · 8 markets · 99 records

Nateglinide 8 markets · 99 records Forms

CN 59 records · 5 strengths

  • 30 mgtablet丹平那格列奈可宾、唐易、唐那、拉姆、贝加、迪方、锡瑞、齐复 +6
  • 120 mgtablet唐力那格列奈贝加、迪方、__mah__:Chen HoPharmaceuticalCo.,Ltd.SinyingPlant、__mah__:山东罗欣药业集团股份有限公司、__mah__:江苏德源药业股份有限公司、__mah__:西安迪赛生物药业有限责任公司 also in US·GB·TW
  • 60 mgtablet贝加那格列奈迪方、__mah__:山东罗欣药业集团股份有限公司、__mah__:珠海同益制药有限公司、__mah__:西安迪赛生物药业有限责任公司 also in US·GB·TW
  • 30 mgcapsule唐苓那格列奈易克亚欣、芙格清、__mah__:施慧达药业集团(吉林)有限公司
  • 90 mgtablet唐易那格列奈齐复

US 18 records · 2 strengths

  • 120 mgtabletNo trade name also in CN·GB·TW
  • 60 mgtabletNo trade name also in CN·GB·TW

GB 10 records · 3 strengths

TW 3 records · 2 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 Trazec

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.